Friday, 23 February 2018

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December ... - GuruFocus.com


Dispatch Tribunal

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December ...
GuruFocus.com
Secondary efficacy endpoints include: (i) the change in serum ferritin, the other key measurement used to detect iron overload, from baseline to end of treatment; and (ii) the requirement for and frequency of phlebotomy procedures used during the study ...
Financial Newsletter - ZacksZacks
La Jolla Pharmaceutical Company - LJPC - Stock Price Today - ZacksZacks

all 22 news articles »


from phlebotomy - Google News http://bit.ly/2CFcvZ0

No comments:

Post a Comment